triazolam has been researched along with Cirrhosis, Liver in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Our findings show that there were no significant differences between the patients with cirrhosis and the control subjects in any of the pharmacokinetic parameters." | 2.67 | Triazolam in cirrhosis: pharmacokinetics and pharmacodynamics. ( Hasan, SS; Lee, M; Robin, DW; Wood, AJ, 1993) |
| "Triazolam 0." | 1.27 | Nighttime dosing of triazolam in patients with liver disease and normal subjects: kinetics and daytime effects. ( Juhl, RP; Kroboth, PD; Smith, RB; Van Thiel, DH, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robin, DW | 1 |
| Lee, M | 1 |
| Hasan, SS | 1 |
| Wood, AJ | 1 |
| Kroboth, PD | 1 |
| Smith, RB | 1 |
| Van Thiel, DH | 1 |
| Juhl, RP | 1 |
1 trial available for triazolam and Cirrhosis, Liver
| Article | Year |
|---|---|
Triazolam in cirrhosis: pharmacokinetics and pharmacodynamics.
Topics: Administration, Oral; Adult; Double-Blind Method; Humans; Liver Cirrhosis; Middle Aged; Posture; Sen | 1993 |
1 other study available for triazolam and Cirrhosis, Liver
| Article | Year |
|---|---|
Nighttime dosing of triazolam in patients with liver disease and normal subjects: kinetics and daytime effects.
Topics: Adult; Circadian Rhythm; Female; Humans; Liver Cirrhosis; Male; Memory; Middle Aged; Psychomotor Per | 1987 |